VERIFICATION OF ANTI-SARS-CoV2 ELISA QUATITATIVE DETECTION METHOD ON THE SEMI-AUTOMATIC IMMUNE MACHINE, HANOI UNIVERSITY OF PUBLIC HEALTH, 2022

Thị Thu Hà Nguyễn1,, Xuân Thắng Trần2, Thị Ngọc Hà Bùi1
1 HUPH
2 HUPHU

Main Article Content

Abstract

Objective: Confirm the precision, trueness, linearity range and reference range of the ELISA method to quantify the concentraion of IgG class antibodies to SARS-CoV-2 on a semi-automatic immune machine at the Hanoi University of Public Health in 2022. Method: We performed  experimental study, collecting data on measuring IgG antibody levels of standard samples, Cal samples and 20 serum samples from study participants using Testline kit on ELISA semi-automatically machine and compared its clinical performance to the CLSI/EP15-A3, EP17-A, CLSI/EP28A-3C kit to evaluate precision, trueness, linear range; confirm the method's reference interval. Result: The precision was not consistent with the manufacturer's announcement; The trueness was confirmed in accordance with the manufacturer's claims at the assigned values of the two QC levels 20 and 80, both within the validation limit (9.22 – 32.06 and 49,418 – 138,922). The linear interval was correlated (r2 = 0.956) between 0.95 and 1, so there was a linear correlation between the measured value and the true value of the sample. Studying a sample size of 20, using the Shapiro-Wilk normal distribution test with a value of sig=0.075 (>0.05), the distribution of anti-SARS-CoV-2 antibody values of 20 volunteers (ages 18-25) was constituted a standard distribution of the study reference range 117.64 – 11243.15U/mL. Conclusion: By confirming the method, the precision of the method at the Testing Center of the University of Public Health was not consistent with the manufacturer's announcement. Laboratories performing test method validation need to adhere to the technical requirements and flexibly apply CLSI guidelines to suit the actual conditions of the laboratory

Article Details

References

1. Nguyễn Thị Ngọc Lan, Tạ Thành Văn, Nguyễn Đình Lộc, Đánh giá phương pháp và giá trị lâm sàng của xét nghiệm Anti-Sars-Cov-2 trên hệ thống Roche Cobas e801 | Tạp chí Nghiên cứu Y học [Internet]. [cited 2022 Jun 27]
2. Immune-mediated approaches against COVID-19 - PubMed [Internet]. [cited 2022 Jun 27]. Available from: https:// pubmed.ncbi.nlm.nih.gov/32661375/
3. Gerhards C, Thiaucourt M, Kittel M, Becker C, Ast V, Hetjens M, et al. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2021 Jun;107:221–7.
4. Clinical and Laboratory Standards Institute (2005). User demonstration of performance for precision and accuracy; Approved guideline. CLSI document EP17-A. Vol. 21 No. 25.
5. Clinical and Laboratory Standards Institute (2014). User verification of Precision and Estimation of Bias; approved guidline. 3rd edition, CLSI document EP15-A3. Vol. 34 No. 12
6. Clinical and Laboratory Standards Institute (2010). Defining, Establishing and Verying Reference Intervals in the Clinical Laboratory; approved guidline. 3rd edition, CLSI document EP28-A3C